EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Gastrointestinal Digestion of Calanus finmarchicus Products: Amino Acid Composition, Degree of Hydrolysis, Antioxidant Capacity, and Antidiabetic Activity

Ying Wang iD, Karl-Erik Eilertsen iD, Edel Oddny Elvevoll iD, Chun Li iD, Ida-Johanne Jensen iD

Marine Drugs · 07.07.2026 · 24 (7) · 240

DOI: 10.3390/md24070240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 07.07.2026. Verfasst von Ying Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biosciences, Fisheries and Economics, The Norwegian College of Fishery Science, UiT-The Arctic University of Norway, 9037 Tromsø, Norway. Hauptthemen laut MEDLINE: Antioxidants, Hypoglycemic Agents, Protein Hydrolysates. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UiT-The Arctic University of Norway, project SECURE-Novel Marine Resources for Food Secu-rity and Food Safety, Norwegian Research Information Repository, UiT—The Arctic University of Norway.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Marine rest raw materials are often undervalued or wasted despite their nutrient and bioactive composition. Calanus finmarchicus, harvested primarily for its omega-3-rich oil, yields a side-stream protein hydrolysate, C. finmarchicus hydrolysate (CFH), during commercial enzyme-assisted extraction. Although currently used as a feed ingredient, CFH contains low-molecular-weight peptides and free amino acids with potential for human health applications. This study evaluated the gastrointestinal stability of CFH and the impact of digestion on bioactivity using a static in vitro gastrointestinal digestion model. Fresh-frozen and freeze-dried C. finmarchicus were included to provide comparative data. Antioxidant capacity was measured by ferric reducing antioxidant power (FRAP) and oxygen radical absorbance capacity (ORAC) assays, and antidiabetic activity by dipeptidyl peptidase-IV (DPP-IV) and protein tyrosine phosphatase 1B (PTP1B) inhibition assays. The hydrolysate maintained its antioxidant capacity throughout digestion (at 165 min: FRAP: 27.5 ± 0.6 µmol TE/g dry weight (DW); ORAC: 411 ± 37 µmol TE/g DW). Digestion increased its DPP-IV inhibitory activity, with the inhibitory concentration (IC50) decreased from 3.73 to 1.96 mg/mL (p ≥ 0.05). PTP1B inhibitors were nonselective and detected only at 0 and 30 min. These findings support our hypothesis that CFH may serve as a nutraceutical for humans and provide a rationale for subsequent in vivo studies. However, further identification of bioactive components and in vivo validation are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsHypoglycemic AgentsProtein HydrolysatesAnimalsAmino AcidsHydrolysisDigestionDipeptidyl-Peptidase IV InhibitorsGastrointestinal TractHumansBioactive Peptides, DietaryProtein Tyrosine Phosphatase, Non-Receptor Type 1

Stichwörter der Autor:innen

Calanus finmarchicusDPP-IVFRAPORACPTP1Bantidiabetic activityantioxidant capacityhydrolysatemarine crustaceannutraceutical

Substanzen

AntioxidantsHypoglycemic AgentsAmino AcidsProtein HydrolysatesDipeptidyl-Peptidase IV InhibitorsBioactive Peptides, DietaryProtein Tyrosine Phosphatase, Non-Receptor Type 1

Autor:innen und Institutionen

  • Faculty of Biosciences, Fisheries and Economics, The Norwegian College of Fishery Science, UiT-The Arctic University of Norway, 9037 Tromsø, Norway.
  • Department of Biotechnology and Food Science, Norwegian University of Science and Technology, NTNU, 7491 Trondheim, Norway.

ORCID-Profile: Ying Wang, Karl-Erik Eilertsen, Edel Oddny Elvevoll, Chun Li, Ida-Johanne Jensen

Förderung

  • UiT-The Arctic University of Norway, project SECURE-Novel Marine Resources for Food Secu-rity and Food Safety, Norwegian Research Information Repository
  • UiT—The Arctic University of Norway

Zitieren

APA

Wang, Y., Eilertsen, K. E., Elvevoll, E. O., Li, C., & Jensen, I. J. (2026). In Vitro Gastrointestinal Digestion of Calanus finmarchicus Products: Amino Acid Composition, Degree of Hydrolysis, Antioxidant Capacity, and Antidiabetic Activity. Marine Drugs, 24(7), 240. https://doi.org/10.3390/md24070240

Vancouver

Wang Y, Eilertsen KE, Elvevoll EO, Li C, Jensen IJ. In Vitro Gastrointestinal Digestion of Calanus finmarchicus Products: Amino Acid Composition, Degree of Hydrolysis, Antioxidant Capacity, and Antidiabetic Activity. Marine Drugs. 2026;24(7):240. doi:10.3390/md24070240

BibTeX
@article{Wang2026,
  author = {Wang, Ying and Eilertsen, Karl-Erik and Elvevoll, Edel Oddny and Li, Chun and Jensen, Ida-Johanne},
  title = {In Vitro Gastrointestinal Digestion of Calanus finmarchicus Products: Amino Acid Composition, Degree of Hydrolysis, Antioxidant Capacity, and Antidiabetic Activity},
  journal = {Marine Drugs},
  year = {2026},
  volume = {24},
  number = {7},
  pages = {240},
  doi = {10.3390/md24070240}
}
Kostenlos starten →